Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Stefania Morganti, M.D.

Concepts (109)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms182024211561.160 Why?
High-Throughput Nucleotide Sequencing2201936650.530 Why?
Pharmacogenetics120196770.470 Why?
Receptor, erbB-29202425860.410 Why?
Drug Resistance, Neoplasm3202453420.350 Why?
Neoplasms82024223860.320 Why?
BRCA2 Protein220248020.310 Why?
Data Interpretation, Statistical1201827050.310 Why?
BRCA1 Protein2202411580.280 Why?
Antineoplastic Agents72024137080.250 Why?
Immunoconjugates220239680.230 Why?
Immunotherapy6202447280.230 Why?
Receptors, Estrogen2202322430.230 Why?
Epirubicin12022810.210 Why?
Genomics1201859090.200 Why?
Clinical Trials, Phase III as Topic320208760.190 Why?
Receptors, Fibroblast Growth Factor120211960.180 Why?
Phthalazines120233960.180 Why?
Female2320243969430.160 Why?
Receptors, Progesterone1202311450.160 Why?
Fluorouracil1202216560.140 Why?
Protein Kinase Inhibitors3202457090.140 Why?
Bone Resorption120217270.140 Why?
Prognosis52024300280.140 Why?
Cyclophosphamide1202222240.140 Why?
Humans3120247684510.130 Why?
Ketones120171820.130 Why?
Furans120172010.130 Why?
Proto-Oncogene Proteins c-akt1202424650.130 Why?
Fibroblast Growth Factors120218730.130 Why?
Antineoplastic Combined Chemotherapy Protocols52024118430.120 Why?
Disease-Free Survival2202268560.120 Why?
Lymphocytes, Tumor-Infiltrating1202111040.120 Why?
Clinical Trials, Phase II as Topic320246370.120 Why?
Germ-Line Mutation1202318840.120 Why?
Neoplasms, Second Primary1202210620.120 Why?
Carcinoma, Intraductal, Noninfiltrating120219340.120 Why?
Neoplasm Recurrence, Local2202394250.110 Why?
Carcinoma, Ductal, Breast1202110920.110 Why?
Chemotherapy, Adjuvant1202235500.110 Why?
Immunologic Factors1202316000.110 Why?
Diagnostic Tests, Routine120187920.100 Why?
Neoplasm Metastasis5202149310.100 Why?
History, 21st Century1201815750.100 Why?
Carcinoma, Non-Small-Cell Lung2202054260.100 Why?
Tumor Microenvironment2202139390.090 Why?
Clinical Trials, Phase I as Topic220243300.090 Why?
Recurrence1202385100.090 Why?
Adiposity1202118880.090 Why?
History, 20th Century1201827720.090 Why?
Bone Neoplasms1202125620.080 Why?
Randomized Controlled Trials as Topic32020103580.080 Why?
Mutation32024302430.080 Why?
Medical Oncology1202023470.070 Why?
Neoplasm Staging22020112490.070 Why?
Immunohistochemistry12021111380.070 Why?
Prevalence12024158800.070 Why?
Lung Neoplasms22020135890.060 Why?
Case-Control Studies12023222930.060 Why?
Treatment Outcome42024654090.060 Why?
Aged, 80 and over32024596800.060 Why?
Adult620242235420.060 Why?
Risk Assessment22022243110.050 Why?
Body Mass Index12021130300.050 Why?
Research Design1201862170.050 Why?
Neoadjuvant Therapy2202428960.050 Why?
Disease Progression12018136550.050 Why?
Aged620241715200.050 Why?
Middle Aged720242234180.050 Why?
Drug Synergism1202417650.040 Why?
Immunotoxins120201750.040 Why?
Organ Specificity1202419720.040 Why?
Molecular Targeted Therapy2202128340.040 Why?
Oxazoles120201990.040 Why?
Young Adult22024600450.040 Why?
Antibodies, Monoclonal3202092630.040 Why?
Prospective Studies12024549140.040 Why?
Cell Death1202416840.040 Why?
Obesity12021130650.040 Why?
Lymphocyte Count120207930.040 Why?
Xenograft Model Antitumor Assays1202436190.030 Why?
Survival Rate22021128750.030 Why?
Retreatment120176010.030 Why?
Retrospective Studies52024818340.030 Why?
Histone Deacetylase Inhibitors120207760.030 Why?
Drug Therapy, Combination1202463200.030 Why?
Quinazolines1202013760.030 Why?
Drug Discovery1202110620.030 Why?
Breast1202119760.030 Why?
Lymphocytes1202026110.030 Why?
Cancer Vaccines1202010440.030 Why?
Biopsy1202468160.020 Why?
Pyridines1202028880.020 Why?
Cell Line, Tumor12024171490.020 Why?
Quality of Life22021134970.020 Why?
Neutrophils1202037900.020 Why?
Age Factors12024184780.020 Why?
Cell Differentiation12024116740.020 Why?
Kaplan-Meier Estimate1201765370.020 Why?
Cell Proliferation12021104940.020 Why?
Animals320241694180.020 Why?
Gene Expression Regulation, Neoplastic1202186350.020 Why?
Clinical Trials as Topic1202080510.010 Why?
Male320243647810.010 Why?
Algorithms12020141580.010 Why?
Time Factors12021402710.010 Why?
Signal Transduction12021236380.010 Why?
Mice12024820450.010 Why?
Risk Factors12021749150.010 Why?
Morganti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (109)
Explore
_
Co-Authors (28)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.